Panretinal Photocoagulation (PRP) Plus Ranibizumab for Proliferative Diabetic Retinopathy

NCT01102946 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Retinopathy
Retinal Neovascularization

Interventions

DRUG: Ranibizumab
PROCEDURE: Panretinal Photocoagulation

Sponsor

University of Sao Paulo